Results 161 to 170 of about 1,098,931 (194)

Cutaneous adverse reactions to Bruton tyrosine kinase inhibitors: Banal to brutal

Journal of the American Academy of Dermatology, 2023
Warren R Heymann
exaly  

Progress in the development of small molecular inhibitors of the Bruton’s tyrosine kinase (BTK) as a promising cancer therapy

Bioorganic and Medicinal Chemistry, 2021
Saiyang Zhang, Jian Song, Guang-Xi Yu
exaly  

Discovery of potent and selective reversible Bruton’s tyrosine kinase inhibitors

Bioorganic and Medicinal Chemistry, 2021
Ariele Viacava Follis, Hui Qiu, Anna S Gardberg   +2 more
exaly  

Bruton's tyrosine kinase inhibitors

2022
LIAO XIBIN, LV YUBIN
openaire   +2 more sources

Bruton’s Tyrosine Kinase Inhibitors: A New Generation of Promising Agents for Multiple Sclerosis Therapy

Cells, 2021
exaly  

Bruton tyrosine kinase inhibitors for Waldenström macroglobulinemia: A review.

Journal of Oncology Pharmacy Practice, 2021

exaly  

Next-generation Bruton’s Tyrosine Kinase (BTK) Inhibitors Potentially Targeting BTK C481S Mutation- Recent Developments and Perspectives

Current Topics in Medicinal Chemistry, 2022

exaly  

Non-Covalent Bruton’s Tyrosine Kinase Inhibitors in the Treatment of Chronic Lymphocytic Leukemia

Cancers, 2023
Skye Montoya, Meghan C. Thompson
exaly  

INHIBITORS OF BRUTON'S TYROSINE KINASE

2008
HONIGBERG LEE, VERNER ERIK J, BUGGY JOSEPH J, LOURY DAVID J, CHEN WEI   +4 more
openaire   +18 more sources

Inhibitors of Bruton's tyrosine kinase

2018
LEE SEUNG, YAMAMOTO SHINGO
openaire   +5 more sources